Moneycontrol

Budget 2021

Associate Partners:

  • SMC
  • Samsung
  • Volvo

Moneycontrol

Budget 2021

Associate Partners:

  • SMCSamsungVolvo
Webinar :Join an expert panel for a webinar on Smart investments for a secure retirement January 28, 2021. Register now!

COVID-19 vaccine update | Bharat Biotech air-ships Covaxin to 11 cities

The Hyderabad-based vaccine major said it has donated 16.5 lakh doses to the Government of India.

January 13, 2021 / 09:02 PM IST
Representative image

Representative image

Bharat Biotech on Wednesday said it successfully air-shipped its COVID-19 vaccine, Covaxin, to 11 cities across the country.

The Hyderabad-based vaccine major said it has donated 16.5 lakh doses to the Government of India. "After having received the government purchase order for 55 lakh doses, the company shipped the first batch of vaccines (each vial containing 20 doses)," Bharat Biotech said in a statement.

Air India transports first consignment of Bharat Biotech vaccine Covaxin

It added that the vaccine have been sent to Ganavaram, Guwahati, Patna, Delhi, Kurukshetra, Bengaluru, Pune, Bhubaneswar, Jaipur, Chennai and Lucknow. On Wednesday, the company also inked a pact with Precisa Medicamentos, a Brazilian company, to supply the COVID-19 vaccine candidate to the Latin American country.

Covaxin has been developed by Bharat Biotech in collaboration with the Indian Council of Medical Research and the National Institute of Virology. The Covid-19 vaccine has been developed and manufactured in Hyderabad-based bio-containment facility.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show
Earlier, this month, India's drugs regulator DCGI approved the Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute of India, and indigenously-developed Covaxin, for restricted emergency use in the country.
PTI
first published: Jan 13, 2021 09:02 pm

stay updated

Get Daily News on your Browser
Sections